FOLH1 and cancer: We addressed this void and relied on the Frankfurt Metastatic Cancer Database of the Prostate (FRAMCAP), to compare cancer control outcomes such as PFS and OS in radium- 223-pretreated vs. radium- 223-naïve Lu- 177-PSMA mCRPC patients.